Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M833Revenue (TTM) $M6.5Net Margin (%)-2,600.8Altman Z-Score-12.2
Enterprise Value $M766EPS (TTM) $-1.4Operating Margin %-2,577.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-8.6Pre-tax Margin (%)-2,600.8Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-3.9Quick Ratio5.3Cash flow > EarningsY
Price/Sales1285-y EBITDA Growth Rate %-1.6Current Ratio5.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-143.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ZIOP is held by these investors:



ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-51.01view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-37.85view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-35.15view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-34.82view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-28.11view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.579.71view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.220.96view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9926.05view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9227.85view
Fowler WycheDirector 2011-08-10Buy5,000$5.1921.19view

Press Releases about ZIOP :

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
ZIOPHARM Oncology Announces Pricing of $50 Million Follow-On Offering of Common Stock May 12 2017 
ZIOPHARM Oncology Announces FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting Rel May 02 2017 
ZIOPHARM Oncology Reports First Quarter 2017 Financial Results and Provides Update on Recent Activit May 01 2017 
ZIOPHARM Oncology to Host First-Quarter 2017 Financial Results and Corporate Update Conference Call Apr 24 2017 
ZIOPHARM Oncology to Present Updated Clinical Results of Gene Therapy Candidate Ad-RTS-hIL-12 + Vele Apr 20 2017 
Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Pla Apr 03 2017 
ZIOPHARM Announces Successful End-of-Phase 2 Meeting with FDA for Ad-RTS-hIL-12 Gene Therapy in Rec Mar 27 2017 
ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications Mar 27 2017 
Intrexon Corp is expanding his business Jun 25 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 

More From Other Websites
ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bearish Manner : ZIOP-US : May 26,... May 26 2017
Edited Transcript of ZIOP earnings conference call or presentation 1-May-17 8:30pm GMT May 22 2017
What You Missed in Intrexon's Quarterly Report May 18 2017
ZIOPHARM Oncology Announces Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma to be... May 17 2017
ETFs with exposure to ZIOPHARM Oncology, Inc. : May 15, 2017 May 15 2017
Ziopharm Prices Secondary Offering May 12 2017
Ziopharm Oncology's stock tumbles after stock offering prices at deep discount May 12 2017
ZIOPHARM Oncology Announces Pricing of $50 Million Follow-On Offering of Common Stock May 12 2017
Intrexon (XON) Q1 Loss Wider than Expected, Revenues Beat May 11 2017
Why Intrexon Is Soaring Today May 11 2017
ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017 May 03 2017
ZIOPHARM Oncology Announces FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting... May 02 2017
Ziopharm reports 1Q loss May 01 2017
ZIOPHARM Oncology Reports First Quarter 2017 Financial Results and Provides Update on Recent... May 01 2017
Investor Network: ZIOPHARM Oncology, Inc. to Host Earnings Call May 01 2017
ZIOPHARM Oncology to Host First-Quarter 2017 Financial Results and Corporate Update Conference Call... Apr 24 2017
Today's Research Reports on Biotech Stocks to Watch: Idera Pharmaceuticals and ZIOPHARM Oncology Apr 21 2017
ZIOPHARM Oncology to Present Updated Clinical Results of Gene Therapy Candidate Ad-RTS-hIL-12 +... Apr 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)